The Business Research Company’s Breast Cancer Diagnostics Global Market Report 2022 – Market Size, Trends, And Global Forecast 2022-2026
LONDON, GREATER LONDON, UK, September 21, 2022 /EINPresswire.com/ — As per The Business Research Company’s “Breast Cancer Diagnostics Global Market Report 2022”, the breast cancer diagnostics market is expected to grow from $3.75 billion in 2021 to $4.06 billion in 2022 at a compound annual growth rate (CAGR) of 8.3%. As per TBRC’s breast cancer diagnostics market outlook the market is then expected to grow to $5.48 billion in 2026 at a CAGR of 7.8%. The increasing incidence of breast cancer will require more equipment to diagnose, which will further increase the demand for the breast cancer diagnostics market.
Request a Sample now to gain a better understanding of breast cancer diagnostics market:
Key Trends In The Breast Cancer Diagnostics Market
Technological advancement is a key trend in the breast cancer diagnostics market. Several new techniques have been developed which could be used in the diagnosis and treatment of breast cancer. The 3D mammography, also known as breast tomosynthesis, takes photographs around the breast from various angles and translates them into a 3-D model.
Overview Of The Breast Cancer Diagnostics Market
The breast cancer diagnostics market consists of sales of breast cancer diagnostic devices and related services by entities (organizations, sole traders, and partnerships) that produce breast cancer diagnostics devices. These devices are used to diagnose breast cancer. Only goods and services traded between entities or sold to end consumers are included.
Learn more on the global breast cancer diagnostics market report at:
Breast Cancer Diagnostics Global Market Report 2022 from TBRC covers the following information:
Market Size Data
• Forecast period: Historical and Future
• By region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
• By countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
• By Type: Imaging, Biopsy, Genomic Tests, Blood Tests, Others
• By Technology: Fluorescent In Situ Hybridization (FISH), Comparative Genomic Hybridization (CGH), Immunohistochemical (IHC), Others
• By Cancer Type: BRCA Breast Cancer, ER and PR Breast Cancer, HER 2 Breast Cancer, EGFR Mutation Test Breast Cancer, Others
• By Diagnostic Type: Ionizing Breast Imaging Technologies, Non-Ionizing Imaging Technologies
• By End-User: Hospitals and Clinics, Cancer Research Centers, Diagnostic Laboratories, Ambulatory Surgical Centers
• By Geography: The global breast cancer diagnostics market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa. Among these regions, North America holds the largest share in the market.
Major market players such as Abbott Laboratories, Myriad Genetics Inc, Hologic Inc, Koninklijke Philips N.V, Fujifilm Holdings Corporation, GE Healthcare, Thermo Fischer Scientific Inc, Siemens AG, NanoString Technologies Inc, and C. R. Bard Inc.
Trends, opportunities, strategies and so much more.
Breast Cancer Diagnostics Global Market Report 2022 is one of The Business Research Company’s comprehensive reports that provides a breast cancer diagnostics market overview. The market report gives breast cancer diagnostics global market analysis, breast cancer diagnostics global market size, breast cancer diagnostics global market growth drivers, breast cancer diagnostics global market segments, breast cancer diagnostics global market major players, breast cancer diagnostics global market growth across geographies, and breast cancer diagnostics market competitors’ revenues and market positioning. The breast cancer diagnostics global market research report enables you to gain insights on opportunities and strategies, as well as identify countries and segments with the highest growth potential.
Not what you were looking for? Go through similar reports by The Business Research Company:
Breast Imaging Devices Market 2022
Breast Cancer Monoclonal Antibodies Global Market Report 2022
Cancer Clinical Decision Tools Global Market Report 2022
About The Business Research Company
The Business Research Company has published over 3000 industry reports, covering over 3000 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Check out our:
TBRC Blog: http://blog.tbrc.info/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Market Research Products, Services, Solutions For Your Business – TBRC